{"id": "1354429438436339716", "creation": 1611756116.0, "user_id": "1254035253104181256", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "$ONCS OncoSec Announces First Subjects Dosed in Phase 1 Trial of CORVax12, OncoSec's COVID-19 Vaccine Candidate Combining Interleukin-12 (IL-12) with an Enhanced SARS-CoV-2 Spike Protein\nhttps://t.co/jn8Ra9tHVT\n\n#vaccine #covid19", "first_save": 1634559108.199414, "hashtags": ["#VACCINE", "#COVID19"]}